In a filing, Harmony Biosciences Holdings Inc revealed its 10% Owner Valor IV Pharma Holdings, LLC unloaded Company’s shares for reported $121.21 million on Nov 01 ’24. In the deal valued at $30.30 per share,4,000,000 shares were sold. As a result of this transaction, Valor IV Pharma Holdings, LLC now holds 7,218,033 shares worth roughly $238.63 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Valor IV Pharma Holdings, LLC sold 600,000 shares, generating $18,181,500 in total proceeds. Upon selling the shares at $30.30, the 10% Owner now owns 6,618,033 shares.
Before that, Marshman Fund Trust II sold 4,000,000 shares. Harmony Biosciences Holdings Inc shares valued at $121,210,000 were divested by the 10% Owner at a price of $30.30 per share. As a result of the transaction, Marshman Fund Trust II now holds 6,651,120 shares, worth roughly $219.89 million.
A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in early September with a ‘”a Buy”‘ rating. Citigroup began covering HRMY with “Buy” recommendation on June 21, 2024. BofA Securities revised its rating on January 02, 2024. It rated HRMY as “an Underperform” which previously was an “a Neutral”.
Price Performance Review of HRMY
On Monday, Harmony Biosciences Holdings Inc [NASDAQ:HRMY] saw its stock jump 2.07% to $33.06. Over the last five days, the stock has lost -1.25%. Harmony Biosciences Holdings Inc shares have risen nearly 2.35% since the year began. Nevertheless, the stocks have fallen -2.13% over the past one year. While a 52-week high of $41.61 was reached on 10/29/24, a 52-week low of $28.14 was recorded on 04/25/24. SMA at 50 days reached $34.26, while 200 days put it at $33.02.
Levels Of Support And Resistance For HRMY Stock
The 24-hour chart illustrates a support level at 32.46, which if violated will result in even more drops to 31.86. On the upside, there is a resistance level at 33.38. A further resistance level may holdings at 33.70. The Relative Strength Index (RSI) on the 14-day chart is 46.00, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.34, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.26%. Stochastics %K at 18.51% indicates the stock is a buying.
How much short interest is there in Harmony Biosciences Holdings Inc?
A steep rise in short interest was recorded in Harmony Biosciences Holdings Inc stocks on 2024-11-29, dropping by -0.61 million shares to a total of 5.45 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 6.06 million shares. There was a decline of -11.22%, which implies that there is a negative sentiment for the stock.
